Correlation of amyloid PET ligand florbetapir F 18 (18F-AV-45) binding with β-amyloid aggregation and neuritic plaque deposition in postmortem brain tissue
Identifieur interne : 001264 ( Main/Exploration ); précédent : 001263; suivant : 001265Correlation of amyloid PET ligand florbetapir F 18 (18F-AV-45) binding with β-amyloid aggregation and neuritic plaque deposition in postmortem brain tissue
Auteurs : Seok Rye Choi [États-Unis] ; Julie A. Schneider ; David A. Bennett ; Thomas G. Beach [États-Unis] ; Barry J. Bedell [Canada] ; Simone P. Zehntner [Canada] ; Michael Krautkramer [États-Unis] ; Hank F. Kung [États-Unis] ; Daniel M. Skovronsky [États-Unis] ; Franz Hefti [États-Unis] ; Christopher M. Clark [États-Unis]Source :
- Alzheimer Disease and Associated Disorders [ 0893-0341 ] ; 2012.
Abstract
Florbetapir F 18 (18F-AV-45) is a positron emission tomography (PET) imaging ligand for the detection of amyloid aggregation associated with Alzheimer’s disease. Earlier data showed that florbetapir F 18 binds with high affinity to β-amyloid plaques in human brain homogenates (Kd = 3.7 nM) and has favorable imaging pharmacokinetic properties, including rapid brain penetration and washout. The present study used human autopsy brain tissue to evaluate the correlation between
The localization and density of florbetapir F 18 binding in frozen and formalin-fixed paraffin-embedded sections of postmortem brain tissue from 40 subjects with a varying degree of neurodegenerative pathology was assessed by standard florbetapir F 18 autoradiography and correlated with the localization and density of β-amyloid identified by silver staining, thioflavin S staining, and immunohistochemistry.
There were strong quantitative correlations between florbetapir F 18 tissue binding and both β-amyloid plaques identified by light microscopy (sliver staining and thioflavin S fluorescence) and by immunohistochemical measurements of β-amyloid using three antibodies recognizing different epitopes of the β-amyloid peptide (Aβ). Florbetapir F 18 did not bind to neurofibrillary tangles.
Florbetapir F 18 selectively binds β-amyloid in human brain tissue. The binding intensity was quantitatively correlated with the density of β-amyloid plaques identified by standard neuropathological techniques and correlated with the density of Aβ measured by immunohistochemistry. Since β-amyloid plaques are a defining neuropathological feature for Alzheimer’s disease, these results support the use of florbetapir F 18 as an amyloid PET ligand to identify the presence of AD pathology in patients with signs and symptoms of progressive late-life cognitive impairment.
Url:
DOI: 10.1097/WAD.0b013e31821300bc
PubMed: 22354138
PubMed Central: 3286131
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000478
- to stream Pmc, to step Curation: 000478
- to stream Pmc, to step Checkpoint: 000850
- to stream Ncbi, to step Merge: 001070
- to stream Ncbi, to step Curation: 001070
- to stream Ncbi, to step Checkpoint: 001070
- to stream Main, to step Merge: 001292
- to stream Main, to step Curation: 001264
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Correlation of amyloid PET ligand florbetapir F 18 (<sup>18</sup>
F-AV-45) binding with β-amyloid aggregation and neuritic plaque deposition in postmortem brain tissue</title>
<author><name sortKey="Choi, Seok Rye" sort="Choi, Seok Rye" uniqKey="Choi S" first="Seok Rye" last="Choi">Seok Rye Choi</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Schneider, Julie A" sort="Schneider, Julie A" uniqKey="Schneider J" first="Julie A." last="Schneider">Julie A. Schneider</name>
<affiliation><nlm:aff id="A2"> Department of Pathology, Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago IL</nlm:aff>
<wicri:noCountry code="subfield">Chicago IL</wicri:noCountry>
</affiliation>
<affiliation><nlm:aff id="A3"> Department of Neurological Sciences, Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago IL</nlm:aff>
<wicri:noCountry code="subfield">Chicago IL</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bennett, David A" sort="Bennett, David A" uniqKey="Bennett D" first="David A." last="Bennett">David A. Bennett</name>
<affiliation><nlm:aff id="A3"> Department of Neurological Sciences, Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago IL</nlm:aff>
<wicri:noCountry code="subfield">Chicago IL</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Beach, Thomas G" sort="Beach, Thomas G" uniqKey="Beach T" first="Thomas G." last="Beach">Thomas G. Beach</name>
<affiliation wicri:level="2"><nlm:aff id="A4"> Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
<wicri:cityArea> Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bedell, Barry J" sort="Bedell, Barry J" uniqKey="Bedell B" first="Barry J." last="Bedell">Barry J. Bedell</name>
<affiliation wicri:level="1"><nlm:aff id="A5"> Biospective Inc, Montreal, Quebec, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Biospective Inc, Montreal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:aff id="A6"> Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Montreal Neurological Institute, McGill University, Montreal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zehntner, Simone P" sort="Zehntner, Simone P" uniqKey="Zehntner S" first="Simone P." last="Zehntner">Simone P. Zehntner</name>
<affiliation wicri:level="1"><nlm:aff id="A5"> Biospective Inc, Montreal, Quebec, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Biospective Inc, Montreal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Krautkramer, Michael" sort="Krautkramer, Michael" uniqKey="Krautkramer M" first="Michael" last="Krautkramer">Michael Krautkramer</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kung, Hank F" sort="Kung, Hank F" uniqKey="Kung H" first="Hank F." last="Kung">Hank F. Kung</name>
<affiliation wicri:level="2"><nlm:aff id="A7"> Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Radiology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A8"> Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Pharmacology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A9"> Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Neurology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Skovronsky, Daniel M" sort="Skovronsky, Daniel M" uniqKey="Skovronsky D" first="Daniel M." last="Skovronsky">Daniel M. Skovronsky</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A7"> Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Radiology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hefti, Franz" sort="Hefti, Franz" uniqKey="Hefti F" first="Franz" last="Hefti">Franz Hefti</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Clark, Christopher M" sort="Clark, Christopher M" uniqKey="Clark C" first="Christopher M." last="Clark">Christopher M. Clark</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A9"> Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Neurology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">22354138</idno>
<idno type="pmc">3286131</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286131</idno>
<idno type="RBID">PMC:3286131</idno>
<idno type="doi">10.1097/WAD.0b013e31821300bc</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000478</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000478</idno>
<idno type="wicri:Area/Pmc/Curation">000478</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000478</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000850</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000850</idno>
<idno type="wicri:Area/Ncbi/Merge">001070</idno>
<idno type="wicri:Area/Ncbi/Curation">001070</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001070</idno>
<idno type="wicri:doubleKey">0893-0341:2012:Choi S:correlation:of:amyloid</idno>
<idno type="wicri:Area/Main/Merge">001292</idno>
<idno type="wicri:Area/Main/Curation">001264</idno>
<idno type="wicri:Area/Main/Exploration">001264</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Correlation of amyloid PET ligand florbetapir F 18 (<sup>18</sup>
F-AV-45) binding with β-amyloid aggregation and neuritic plaque deposition in postmortem brain tissue</title>
<author><name sortKey="Choi, Seok Rye" sort="Choi, Seok Rye" uniqKey="Choi S" first="Seok Rye" last="Choi">Seok Rye Choi</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Schneider, Julie A" sort="Schneider, Julie A" uniqKey="Schneider J" first="Julie A." last="Schneider">Julie A. Schneider</name>
<affiliation><nlm:aff id="A2"> Department of Pathology, Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago IL</nlm:aff>
<wicri:noCountry code="subfield">Chicago IL</wicri:noCountry>
</affiliation>
<affiliation><nlm:aff id="A3"> Department of Neurological Sciences, Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago IL</nlm:aff>
<wicri:noCountry code="subfield">Chicago IL</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Bennett, David A" sort="Bennett, David A" uniqKey="Bennett D" first="David A." last="Bennett">David A. Bennett</name>
<affiliation><nlm:aff id="A3"> Department of Neurological Sciences, Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago IL</nlm:aff>
<wicri:noCountry code="subfield">Chicago IL</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Beach, Thomas G" sort="Beach, Thomas G" uniqKey="Beach T" first="Thomas G." last="Beach">Thomas G. Beach</name>
<affiliation wicri:level="2"><nlm:aff id="A4"> Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, AZ</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Arizona</region>
</placeName>
<wicri:cityArea> Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Bedell, Barry J" sort="Bedell, Barry J" uniqKey="Bedell B" first="Barry J." last="Bedell">Barry J. Bedell</name>
<affiliation wicri:level="1"><nlm:aff id="A5"> Biospective Inc, Montreal, Quebec, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Biospective Inc, Montreal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4"><nlm:aff id="A6"> Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Montreal Neurological Institute, McGill University, Montreal, Quebec</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName><settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Zehntner, Simone P" sort="Zehntner, Simone P" uniqKey="Zehntner S" first="Simone P." last="Zehntner">Simone P. Zehntner</name>
<affiliation wicri:level="1"><nlm:aff id="A5"> Biospective Inc, Montreal, Quebec, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea> Biospective Inc, Montreal, Quebec</wicri:regionArea>
<wicri:noRegion>Quebec</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Krautkramer, Michael" sort="Krautkramer, Michael" uniqKey="Krautkramer M" first="Michael" last="Krautkramer">Michael Krautkramer</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Kung, Hank F" sort="Kung, Hank F" uniqKey="Kung H" first="Hank F." last="Kung">Hank F. Kung</name>
<affiliation wicri:level="2"><nlm:aff id="A7"> Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Radiology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A8"> Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Pharmacology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A9"> Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Neurology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Skovronsky, Daniel M" sort="Skovronsky, Daniel M" uniqKey="Skovronsky D" first="Daniel M." last="Skovronsky">Daniel M. Skovronsky</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A7"> Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Radiology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Hefti, Franz" sort="Hefti, Franz" uniqKey="Hefti F" first="Franz" last="Hefti">Franz Hefti</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Clark, Christopher M" sort="Clark, Christopher M" uniqKey="Clark C" first="Christopher M." last="Clark">Christopher M. Clark</name>
<affiliation wicri:level="2"><nlm:aff id="A1"> Avid Radiopharmaceutical Inc., Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Avid Radiopharmaceutical Inc., Philadelphia</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A9"> Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
<wicri:cityArea> Department of Neurology, University of Pennsylvania, Philadelphia</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Alzheimer Disease and Associated Disorders</title>
<idno type="ISSN">0893-0341</idno>
<idno type="eISSN">1546-4156</idno>
<imprint><date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">Florbetapir F 18 (<sup>18</sup>
F-AV-45) is a positron emission tomography (PET) imaging ligand for the detection of amyloid aggregation associated with Alzheimer’s disease. Earlier data showed that florbetapir F 18 binds with high affinity to β-amyloid plaques in human brain homogenates (Kd = 3.7 nM) and has favorable imaging pharmacokinetic properties, including rapid brain penetration and washout. The present study used human autopsy brain tissue to evaluate the correlation between <italic>in vitro</italic>
florbetapir F 18 binding and β-amyloid density measured by established neuropathological methods.</p>
</sec>
<sec sec-type="methods" id="S2"><title>Methods</title>
<p id="P2">The localization and density of florbetapir F 18 binding in frozen and formalin-fixed paraffin-embedded sections of postmortem brain tissue from 40 subjects with a varying degree of neurodegenerative pathology was assessed by standard florbetapir F 18 autoradiography and correlated with the localization and density of β-amyloid identified by silver staining, thioflavin S staining, and immunohistochemistry.</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P3">There were strong quantitative correlations between florbetapir F 18 tissue binding and both β-amyloid plaques identified by light microscopy (sliver staining and thioflavin S fluorescence) and by immunohistochemical measurements of β-amyloid using three antibodies recognizing different epitopes of the β-amyloid peptide (Aβ). Florbetapir F 18 did not bind to neurofibrillary tangles.</p>
</sec>
<sec id="S4"><title>Conclusion</title>
<p id="P4">Florbetapir F 18 selectively binds β-amyloid in human brain tissue. The binding intensity was quantitatively correlated with the density of β-amyloid plaques identified by standard neuropathological techniques and correlated with the density of Aβ measured by immunohistochemistry. Since β-amyloid plaques are a defining neuropathological feature for Alzheimer’s disease, these results support the use of florbetapir F 18 as an amyloid PET ligand to identify the presence of AD pathology in patients with signs and symptoms of progressive late-life cognitive impairment.</p>
</sec>
</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>Arizona</li>
<li>Pennsylvanie</li>
<li>Québec</li>
</region>
<settlement><li>Montréal</li>
</settlement>
<orgName><li>Université McGill</li>
</orgName>
</list>
<tree><noCountry><name sortKey="Bennett, David A" sort="Bennett, David A" uniqKey="Bennett D" first="David A." last="Bennett">David A. Bennett</name>
<name sortKey="Schneider, Julie A" sort="Schneider, Julie A" uniqKey="Schneider J" first="Julie A." last="Schneider">Julie A. Schneider</name>
</noCountry>
<country name="États-Unis"><region name="Pennsylvanie"><name sortKey="Choi, Seok Rye" sort="Choi, Seok Rye" uniqKey="Choi S" first="Seok Rye" last="Choi">Seok Rye Choi</name>
</region>
<name sortKey="Beach, Thomas G" sort="Beach, Thomas G" uniqKey="Beach T" first="Thomas G." last="Beach">Thomas G. Beach</name>
<name sortKey="Clark, Christopher M" sort="Clark, Christopher M" uniqKey="Clark C" first="Christopher M." last="Clark">Christopher M. Clark</name>
<name sortKey="Clark, Christopher M" sort="Clark, Christopher M" uniqKey="Clark C" first="Christopher M." last="Clark">Christopher M. Clark</name>
<name sortKey="Hefti, Franz" sort="Hefti, Franz" uniqKey="Hefti F" first="Franz" last="Hefti">Franz Hefti</name>
<name sortKey="Krautkramer, Michael" sort="Krautkramer, Michael" uniqKey="Krautkramer M" first="Michael" last="Krautkramer">Michael Krautkramer</name>
<name sortKey="Kung, Hank F" sort="Kung, Hank F" uniqKey="Kung H" first="Hank F." last="Kung">Hank F. Kung</name>
<name sortKey="Kung, Hank F" sort="Kung, Hank F" uniqKey="Kung H" first="Hank F." last="Kung">Hank F. Kung</name>
<name sortKey="Kung, Hank F" sort="Kung, Hank F" uniqKey="Kung H" first="Hank F." last="Kung">Hank F. Kung</name>
<name sortKey="Skovronsky, Daniel M" sort="Skovronsky, Daniel M" uniqKey="Skovronsky D" first="Daniel M." last="Skovronsky">Daniel M. Skovronsky</name>
<name sortKey="Skovronsky, Daniel M" sort="Skovronsky, Daniel M" uniqKey="Skovronsky D" first="Daniel M." last="Skovronsky">Daniel M. Skovronsky</name>
</country>
<country name="Canada"><noRegion><name sortKey="Bedell, Barry J" sort="Bedell, Barry J" uniqKey="Bedell B" first="Barry J." last="Bedell">Barry J. Bedell</name>
</noRegion>
<name sortKey="Bedell, Barry J" sort="Bedell, Barry J" uniqKey="Bedell B" first="Barry J." last="Bedell">Barry J. Bedell</name>
<name sortKey="Zehntner, Simone P" sort="Zehntner, Simone P" uniqKey="Zehntner S" first="Simone P." last="Zehntner">Simone P. Zehntner</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001264 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001264 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= PMC:3286131 |texte= Correlation of amyloid PET ligand florbetapir F 18 (18F-AV-45) binding with β-amyloid aggregation and neuritic plaque deposition in postmortem brain tissue }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22354138" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |